Stem/progenitor cell sources of insulin-producing cells for the treatment of diabetes

Tissue Engineering

Volumn 13, Issue 7, 2007, Pages 1399-1412

  Lock, Lye T ^a   Tzanakakis, Emmanuel S ^a,b  

^a the State University of New York   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; INSULIN; PATIENT TREATMENT; TRANSPLANTATION (SURGICAL);

CLINICAL USE; ISLET CELLS; PROGENITOR CELL; STEM CELL;

DISEASE CONTROL;

2 MORPHOLINO 8 PHENYLCHROMONE; ACTIVIN; CYCLOPAMINE; EXENDIN 4; INSULIN; NESTIN; NICOTINAMIDE; PROGESTERONE; RETINOIC ACID;

CELL DIFFERENTIATION; CELL REGENERATION; DIABETES MELLITUS; EMBRYO DEVELOPMENT; EX VIVO STUDY; HUMAN; IN VIVO STUDY; INSULIN RELEASE; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; STEM CELL; SYSTEMATIC REVIEW;

ANIMALS; DIABETES MELLITUS; HUMANS; INSULIN-SECRETING CELLS; STEM CELL TRANSPLANTATION;

EID: 34547134956     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2007.0047     Document Type: Review

References (135)

1. Hogan, P., Dall, T. and Nikolov, P. Economic costs of diabetes in the US in 2002. Diabetes Care 26, 917, 2003.
2. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 2003.
3. Ryan, E.A., Paty, B.W., Senior, P.A., Bigam, D., Alfadhli, E., Kneteman, N.M., Lakey, J.R. and Shapiro, A.M. Five-year follow-up after clinical islet transplantation. Diabetes 54, 2060, 2005.
4. Chick, W.L., Warren, S., Chute, R.N., Like, A.A., Lauris, V. and Kitchen, K.C. A transplantable insulinoma in the rat. Proc Natl Acad Sci U S A 74, 628, 1977.
5. Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P.A. and Wollheim, C.B. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130, 167, 1992.
6. Carrington, C.A., Rubery, E.D., Pearson, E.C. and Hales, C.N. Five new insulin- producing cell lines with differing secretory properties. J Endocrinol 109, 193, 1986.
7. Ishihara, H., Asano, T., Tsukuda, K., Katagiri, H., Inukai, K., Anai, M., Kikuchi, M., Yazaki, Y., Miyazaki, J.I. and Oka, Y. Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets. Diabetologia 36, 1139, 1993.
8. Efrat, S., Linde, S., Kofod, H., Spector, D., Delannoy, M., Grant, S., Hanahan, D. and Baekkeskov, S. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci U S A 85, 9037, 1988.
9. Radvanyi, F., Christgau, S., Baekkeskov, S., Jolicoeur, C. and Hanahan, D. Pancreatic beta cells cultured from individual preneoplastic foci in a multistage tumorigenesis pathway: a potentially general technique for isolating physiologically representative cell lines. Mol Cell Biol 13, 4223, 1993.
10. Efrat, S., Surana, M. and Fleischer, N. Glucose induces insulin gene transcription in a murine pancreatic beta-cell line. J Biol Chem 266, 11141, 1991.
11. Efrat, S., Fusco-DeMane, D., Lemberg, H., al Emran, O. and Wang, X. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci U S A 92, 3576, 1995.
12. Narushima, M., Kobayashi, N., Okitsu, T., Tanaka, Y., Li, S.A., Chen, Y., Miki, A., Tanaka, K., Nakaji, S., Takei, K., Gutierrez, A.S., Rivas-Carrillo, J.D., Navarro-Alvarez, N., Jun, H.S., Westerman, K.A., Noguchi, H., Lakey, J.R., Leboulch, P., Tanaka, N. and Yoon, J.W. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 23, 1274, 2005.
13. Whitesell, R.R., Powers, A.C., Regen, D.M. and Abumrad, N.A. Transport and metabolism of glucose in an insulin-secreting cell line, beta TC-1. Biochemistry 30, 11560, 1991.
14. Lund, K., Blume, N., Michelsen, B.K., Bucchini, D. and Madsen, O.D. Differential expression of non-allelic insulin genes in rodent islet tumour cells. J Mol Endocrinol 11, 305, 1993.
15. Clark, S.A., Quaade, C., Constandy, H., Hansen, P., Halban, P., Ferber, S., Newgard, C.B. and Normington, K. Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes 46, 958, 1997.
16. Minami, K., Yano, H., Miki, T., Nagashima, K., Wang, C.Z., Tanaka, H., Miyazaki, J.I. and Seino, S. Insulin secretion and differential gene expression in glucose-responsive and -unresponsive MIN6 sublines. Am J Physiol Endocrinol Metab 279, E773, 2000.
17. Ferber, S., Beltran del Rio, H., Johnson, J.H., Noel, R.J., Cassidy, L.E., Clark, S., Becker, T.C., Hughes, S.D. and Newgard, C.B. GLUT-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release. Relationship to glucokinase activity. J Biol Chem 269, 11523, 1994.
18. Klug, M.G., Soonpaa, M.H., Koh, G.Y. and Field, L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 98, 216, 1996.
19. Brustle, O., Jones, K.N., Learish, R.D., Karram, K., Choudhary, K., Wiestler, O.D., Duncan, I.D. and McKay, R.D. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285, 754, 1999.
20. Liu, S., Qu, Y., Stewart, T.J., Howard, M.J., Chakrabortty, S., Holekamp, T.F. and McDonald, J.W. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A 97, 6126, 2000.
21. Assady, S., Maor, G., Amit, M., Itskovitz-Eldor, J., Skorecki, K.L. and Tzukerman, M. Insulin production by human embryonic stem cells. Diabetes 50, 1691, 2001.
22. Moritoh, Y., Yamato, E., Yasui, Y., Miyazaki, S. and Miyazaki, J. Analysis of insulin- producing cells during in vitro differentiation from feeder-free embryonic stem cells. Diabetes 52, 1163, 2003.
23. Kahan, B.W., Jacobson, L.M., Hullett, D.A., Ochoada, J.M., Oberley, T.D., Lang, K.M. and Odorico, J.S. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes 52, 2016, 2003.
24. Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R. and McKay, R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389, 2001.
25. Hori, Y., Rulifson, I.C., Tsai, B.C., Heit, J.J., Cahoy, J.D. and Kim, S.K. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 99, 16105, 2002.
26. Hansson, M., Tonning, A., Frandsen, U., Petri, A., Rajagopal, J., Englund, M.C., Heller, R.S., Hakansson, J., Fleckner, J., Skold, H.N., Melton, D., Semb, H. and Serup, P. Artifactual insulin release from differentiated embryonic stem cells. Diabetes 53, 2603, 2004.
27. Rajagopal, J., Anderson, W.J., Kume, S., Martinez, O.I. and Melton, D.A. Insulin staining of ES cell progeny from insulin uptake. Science 299, 363, 2003.
28. Paek, H.J., Morgan, J.R. and Lysaght, M.J. Sequestration and synthesis: the source of insulin in cell clusters differentiated from murine embryonic stem cells. Stem Cells 23, 862, 2005.
29. Blyszczuk, P., Czyz, J., Kania, G., Wagner, M., Roll, U., St-Onge, L. and Wobus, A.M. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci U S A 100, 998, 2003.
30. Shiroi, A., Ueda, S., Ouji, Y., Saito, K., Moriya, K., Sugie, Y., Fukui, H., Ishizaka, S. and Yoshikawa, M. Differentiation of embryonic stem cells into insulin-producing cells promoted by Nkx2.2 gene transfer. World J Gastroenterol 11, 4161, 2005.
31. Leon-Quinto, T., Jones, J., Skoudy, A., Burcin, M. and Soria, B. In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 47, 1442, 2004.
32. Soria, B., Roche, E., Berna, G., Leon-Quinto, T., Reig, J.A. and Martin, F. Insulin- secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49, 157, 2000.
33. Soria, B., Skoudy, A. and Martin, F. From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 44, 407, 2001.
34. Noguchi, H., Kaneto, H., Weir, G.C. and Bonner-Weir, S. PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes 52, 1732, 2003.
35. Noguchi, H., Bonner-Weir, S., Wei, F.Y., Matsushita, M. and Matsumoto, S. BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes 54, 2859, 2005.
36. Dominguez-Bendala, J., Klein, D., Ribeiro, M., Ricordi, C., Inverardi, L., Pastori, R. and Edlund, H. TAT-mediated neurogenin 3 protein transduction stimulates pancreatic endocrine differentiation in vitro. Diabetes 54, 720, 2005.
37. Ku, H.T., Zhang, N., Kubo, A., O'Connor, R., Mao, M., Keller, G. and Bromberg, J.S. Committing embryonic stem cells to early endocrine pancreas in vitro. Stem Cells 22, 1205, 2004.
38. Kubo, A., Shinozaki, K., Shannon, J.M., Kouskoff, V., Kennedy, M., Woo, S., Fehling, H.J. and Keller, G. Development of definitive endoderm from embryonic stem cells in culture. Development 131, 1651, 2004.
39. Yasunaga, M., Tada, S., Torikai-Nishikawa, S., Nakano, Y., Okada, M., Jakt, L.M., Nishikawa, S., Chiba, T., Era, T. and Nishikawa, S. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 23, 1542, 2005.
40. D'Amour, K.A., Agulnick, A.D., Eliazer, S., Kelly, O.G., Kroon, E. and Baetge, E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23, 1534, 2005.
41. D'Amour, K.A., Bang, A.G., Eliazer, S., Kelly, O.G., Agulnick, A.D., Smart, N.G., Moorman, M.A., Kroon, E., Carpenter, M.K. and Baetge, E.E. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24, 1392, 2006.
42. Gu, G., Brown, J.R. and Melton, D.A. Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis. Mech Dev 120, 35, 2003.
43. Meier, J.J., Bhushan, A., Butler, A.E., Rizza, R.A. and Butler, P.C. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48, 2221, 2005.
44. Bonner-Weir, S., Baxter, L.A., Schuppin, G.T. and Smith, F.E. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42, 1715, 1993.
45. Ramiya, V.K., Maraist, M., Arfors, K.E., Schatz, D.A., Peck, A.B. and Cornelius, J.G. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 6, 278, 2000.
46. Bonner-Weir, S., Taneja, M., Weir, G.C., Tatarkiewicz, K., Song, K.H., Sharma, A. and O'Neil, J.J. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 97, 7999, 2000.
47. Dor, Y., Brown, J., Martinez, O.I. and Melton, D.A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41, 2004.
48. Bonner-Weir, S. and Sharma, A. Are there pancreatic progenitor cells from which new islets form after birth? Nat Clin Pract Endocrinol Metab 2, 240, 2006.
49. Lendahl, U., Zimmerman, L.B. and McKay, R.D. CNS stem cells express a new class of intermediate filament protein. Cell 60, 585, 1990.
50. Zulewski, H., Abraham, E.J., Gerlach, M.J., Daniel, P.B., Moritz, W., Muller, B., Vallejo, M., Thomas, M.K. and Habener, J.F. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50, 521, 2001.
51. Huang, H. and Tang, X. Phenotypic determination and characterization of nestin-positive precursors derived from human fetal pancreas. Lab Invest 83, 539, 2003.
52. Piper, K., Ball, S.G., Turnpenny, L.W., Brickwood, S., Wilson, D.I. and Hanley, N.A. Beta-cell differentiation during human development does not rely on nestin-positive precursors: implications for stem cell-derived replacement therapy. Diabetologia 45, 1045, 2002.
53. Treutelaar, M.K., Skidmore, J.M., Dias-Leme, C.L., Hara, M., Zhang, L., Simeone, D., Martin, D.M. and Burant, C.F. Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes 52, 2503, 2003.
54. Seaberg, R.M., Smukler, S.R., Kieffer, T.J., Enikolopov, G., Asghar, Z., Wheeler, M.B., Korbutt, G. and van der Kooy, D. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 22, 1115, 2004.
55. Bouwens, L. Transdifferentiation versus stem cell hypothesis for the regeneration of islet beta-cells in the pancreas. Microsc Res Tech 43, 332, 1998.
56. Lardon, J., Huyens, N., Rooman, I. and Bouwens, L. Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas. Virchows Arch 444, 61, 2004.
57. Minami, K., Okuno, M., Miyawaki, K., Okumachi, A., Ishizaki, K., Oyama, K., Kawaguchi, M., Ishizuka, N., Iwanaga, T. and Seino, S. Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells. Proc Natl Acad Sci U S A 102, 15116, 2005.
58. Okuno, M., Minami, K., Okumachi, A., Miyawaki, K., Yokoi, N., Toyokuni, S. and Seino, S. Generation of insulin-secreting cells from pancreatic acinar cells of animal models of type 1 diabetes. Am J Physiol Endocrinol Metab, 2006.
59. Baeyens, L., De Breuck, S., Lardon, J., Mfopou, J.K., Rooman, I. and Bouwens, L. In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 48, 49, 2005.
60. Baeyens, L., Bonne, S., German, M.S., Ravassard, P., Heimberg, H. and Bouwens, L. Ngn3 expression during postnatal in vitro beta cell neogenesis induced by the JAK/ STAT pathway. Cell Death Differ 13, 1892, 2006.
61. Zalzman, M., Gupta, S., Giri, R.K., Berkovich, I., Sappal, B.S., Karnieli, O., Zern, M.A., Fleischer, N. and Efrat, S. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc Natl Acad Sci U S A 100, 7253, 2003.
62. Nakajima-Nagata, N., Sakurai, T., Mitaka, T., Katakai, T., Yamato, E., Miyazaki, J., Tabata, Y., Sugai, M. and Shimizu, A. In vitro induction of adult hepatic progenitor cells into insulin-producing cells. Biochem Biophys Res Commun 318, 625, 2004.
63. Yang, L., Li, S., Hatch, H., Ahrens, K., Cornelius, J.G., Petersen, B.E. and Peck, A.B. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci U S A 99, 8078, 2002.
64. Cao, L.Z., Tang, D.Q., Horb, M.E., Li, S.W. and Yang, L.J. High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells. Diabetes 53, 3168, 2004.
65. Kojima, H., Fujimiya, M., Matsumura, K., Younan, P., Imaeda, H., Maeda, M. and Chan, L. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 9, 596, 2003.
66. Hess, D., Li, L., Martin, M., Sakano, S., Hill, D., Strutt, B., Thyssen, S., Gray, D.A. and Bhatia, M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21, 763, 2003.
67. Mathews, V., Hanson, P.T., Ford, E., Fujita, J., Polonsky, K.S. and Graubert, T.A. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 53, 91, 2004.
68. Jahr, H. and Bretzel, R.G. Insulin-positive cells in vitro generated from rat bone marrow stromal cells. Transplant Proc 35, 2140, 2003.
69. Chen, L.B., Jiang, X.B. and Yang, L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 10, 3016, 2004.
70. Ianus, A., Holz, G.G., Theise, N.D. and Hussain, M.A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111, 843, 2003.
71. Choi, J.B., Uchino, H., Azuma, K., Iwashita, N., Tanaka, Y., Mochizuki, H., Migita, M., Shimada, T., Kawamori, R. and Watada, H. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 46, 1366, 2003.
72. Lechner, A., Yang, Y.G., Blacken, R.A., Wang, L., Nolan, A.L. and Habener, J.F. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 53, 616, 2004.
73. Nakahata, T. and Ogawa, M. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J Clin Invest 70, 1324, 1982.
74. Lee, M.W., Choi, J., Yang, M.S., Moon, Y.J., Park, J.S., Kim, H.C. and Kim, Y.J. Mesenchymal stem cells from cryopreserved human umbilical cord blood. Biochem Biophys Res Commun 320, 273, 2004.
75. O'Brien, T.A., Tiedemann, K. and Vowels, M.R. No longer a biological waste product: umbilical cord blood. Med J Aust 184, 407, 2006.
76. Pessina, A., Eletti, B., Croera, C., Savalli, N., Diodovich, C. and Gribaldo, L. Pancreas developing markers expressed on human mononucleated umbilical cord blood cells. Biochem Biophys Res Commun 323, 315, 2004.
77. Zhao, Y., Wang, H. and Mazzone, T. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 312, 2454, 2006.
78. Kodama, S., Kuhtreiber, W., Fujimura, S., Dale, E.A. and Faustman, D.L. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302, 1223, 2003.
79. Timper, K., Seboek, D., Eberhardt, M., Linscheid, P., Christ-Crain, M., Keller, U., Muller, B. and Zulewski, H. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 341, 1135, 2006.
80. Hisatomi, Y., Okumura, K., Nakamura, K., Matsumoto, S., Satoh, A., Nagano, K., Yamamoto, T. and Endo, F. Flow cytometric isolation of endodermal progenitors from mouse salivary gland differentiate into hepatic and pancreatic lineages. Hepatology 39, 667, 2004.
81. Ruhnke, M., Ungefroren, H., Nussler, A., Martin, F., Brulport, M., Schormann, W., Hengstler, J.G., Klapper, W., Ulrichs, K., Hutchinson, J.A., Soria, B., Parwaresch, R.M., Heeckt, P., Kremer, B. and Fandrich, F. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 128, 1774, 2005.
82. Wei, J.P., Zhang, T.S., Kawa, S., Aizawa, T., Ota, M., Akaike, T., Kato, K., Konishi, I. and Nikaido, T. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell transplantation 12, 545, 2003.
83. Hori, Y., Gu, X., Xie, X. and Kim, S.K. Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med 2, e103, 2005.
84. Burns, C.J., Minger, S.L., Hall, S., Milne, H., Ramracheya, R.D., Evans, N.D., Persaud, S.J. and Jones, P.M. The in vitro differentiation of rat neural stem cells into an insulin-expressing phenotype. Biochem Biophys Res Commun 326, 570, 2005.
85. Suri, A., Calderon, B., Esparza, T.J., Frederick, K., Bittner, P. and Unanue, E.R. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science 311, 1778, 2006.
86. Nishio, J., Gaglia, J.L., Turvey, S.E., Campbell, C., Benoist, C. and Mathis, D. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 311, 1775, 2006.
87. Chong, A.S., Shen, J., Tao, J., Yin, D., Kuznetsov, A., Hara, M. and Philipson, L.H. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Science 311, 1774, 2006.
88. Finegood, D.T., Scaglia, L. and Bonner-Weir, S. Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44, 249, 1995.
89. Teta, M., Long, S.Y., Wartschow, L.M., Rankin, M.M. and Kushner, J.A. Very slow turnover of beta-cells in aged adult mice. Diabetes 54, 2557, 2005.
90. Bruning, J.C., Winnay, J., Bonner-Weir, S., Taylor, S.I., Accili, D. and Kahn, C.R. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561, 1997.
91. Butler, A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A. and Butler, P.C. Beta- cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102, 2003.
92. Bonner-Weir, S., Trent, D.F. and Weir, G.C. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 71, 1544, 1983.
93. Brockenbrough, J.S., Weir, G.C. and Bonner-Weir, S. Discordance of exocrine and endocrine growth after 90% pancreatectomy in rats. Diabetes 37, 232, 1988.
94. Van Assche, F.A., Aerts, L. and De Prins, F. A morphological study of the endocrine pancreas in human pregnancy. Br J Obstet Gynaecol 85, 818, 1978.
95. Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U. and Perfetti, R. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143, 4397, 2002.
96. Stoffers, D.A., Kieffer, T.J., Hussain, M.A., Drucker, D.J., Bonner-Weir, S., Habener, J.F. and Egan, J.M. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49, 741, 2000.
97. Wang, Q., Li, L., Xu, E., Wong, V., Rhodes, C. and Brubaker, P.L. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia 47, 478, 2004.
98. Xu, G., Stoffers, D.A., Habener, J.F. and Bonner-Weir, S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48, 2270, 1999.
99. Kendall, D.M., Riddle, M.C., Rosenstock, J., Zhuang, D., Kim, D.D., Fineman, M.S. and Baron, A.D. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 28, 1083, 2005.
100. DeFronzo, R.A., Ratner, R.E., Han, J., Kim, D.D., Fineman, M.S. and Baron, A.D. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 28, 1092, 2005.
101. Ahren, B., Pacini, G., Foley, J.E. and Schweizer, A. Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year. Diabetes Care 28, 1936, 2005.
102. Pratley, R.E., Jauffret-Kamel, S., Galbreath, E. and Holmes, D. Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes. Horm Metab Res 38, 423, 2006.
103. Unno, M., Itoh, T., Watanabe, T., Miyashita, H., Moriizumi, S., Teraoka, H., Yonekura, H. and Okamoto, H. Islet beta-cell regeneration and reg genes. Adv Exp Med Biol 321, 61, 1992.
104. Watanabe, T., Yonemura, Y., Yonekura, H., Suzuki, Y., Miyashita, H., Sugiyama, K., Moriizumi, S., Unno, M., Tanaka, O., Kondo, H. and et al. Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci U S A 91, 3589, 1994.
105. Rosenberg, L., Lipsett, M., Yoon, J.W., Prentki, M., Wang, R., Jun, H.S., Pittenger, G.L., Taylor-Fishwick, D. and Vinik, A.I. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. Ann Surg 240, 875, 2004.
106. Beattie, G.M., Montgomery, A.M., Lopez, A.D., Hao, E., Perez, B., Just, M.L., Lakey, J.R., Hart, M.E. and Hayek, A. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes 51, 3435, 2002.
107. Garcia-Ocana, A., Takane, K.K., Reddy, V.T., Lopez-Talavera, J.C., Vasavada, R.C. and Stewart, A.F. Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. J Biol Chem 278, 343, 2003.
108. Garcia-Ocana, A., Takane, K.K., Syed, M.A., Philbrick, W.M., Vasavada, R.C. and Stewart, A.F. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 275, 1226, 2000.
109. Petrik, J., Pell, J.M., Arany, E., McDonald, T.J., Dean, W.L., Reik, W. and Hill, D.J. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 140, 2353, 1999.
110. George, M., Ayuso, E., Casellas, A., Costa, C., Devedjian, J.C. and Bosch, F. Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 109, 1153, 2002.
111. Huotari, M.A., Palgi, J. and Otonkoski, T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen. Endocrinology 139, 1494, 1998.
112. Rooman, I. and Bouwens, L. Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57B16/J mice treated with alloxan. Diabetologia 47, 259, 2004.
113. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S. and Jones, J.M. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145, 1998.
114. Draper, J.S., Smith, K., Gokhale, P., Moore, H.D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T.P., Thomson, J.A. and Andrews, P.W. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22, 53, 2004.
115. Buzzard, J.J., Gough, N.M., Crook, J.M. and Colman, A. Karyotype of human ES cells during extended culture. Nat Biotechnol 22, 381, 2004.
116. Maitra, A., Arking, D.E., Shivapurkar, N., Ikeda, M., Stastny, V., Kassauei, K., Sui, G., Cutler, D.J., Liu, Y., Brimble, S.N., Noaksson, K., Hyllner, J., Schulz, T.C., Zeng, X., Freed, W.J., Crook, J., Abraham, S., Colman, A., Sartipy, P., Matsui, S., Carpenter, M., Gazdar, A.F., Rao, M. and Chakravarti, A. Genomic alterations in cultured human embryonic stem cells. Nat Genet 37, 1099, 2005.
117. Fernandez, L.A., Hatch, E.W., Armann, B., Odorico, J.S., Hullett, D.A., Sollinger, H.W. and Hanson, M.S. Validation of large particle flow cytometry for the analysis and sorting of intact pancreatic islets. Transplantation 80, 729, 2005.
118. Gray, D.W., Gohde, W., Carter, N., Heiden, T. and Morris, P.J. Separation of pancreatic islets by fluorescence-activated sorting. Diabetes 38 Suppl 1, 133, 1989.
119. Pasquali, L., Fan, Y., Trucco, M. and Ringquist, S. Rehabilitation of adaptive immunity and regeneration of beta cells. Trends Biotechnol 24, 516, 2006.
120. Truong, W., Hancock, W.W., Anderson, C.C., Merani, S. and Shapiro, A.M. Coinhibitory T-cell signaling in islet allograft rejection and tolerance. Cell Transplant 15, 105, 2006.
121. Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y. and Benvenisty, N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24, 221, 2006.
122. Li, L., Baroja, M.L., Majumdar, A., Chadwick, K., Rouleau, A., Gallacher, L., Ferber, I., Lebkowski, J., Martin, T., Madrenas, J. and Bhatia, M. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22, 448, 2004.
123. Grinnemo, K.H., Kumagai-Braesch, M., Mansson-Broberg, A., Skottman, H., Hao, X., Siddiqui, A., Andersson, A., Stromberg, A.M., Lahesmaa, R., Hovatta, O., Sylven, C., Corbascio, M. and Dellgren, G. Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online 13, 712, 2006.
124. Grusby, M.J. and Glimcher, L.H. Immune responses in MHC class II-deficient mice. Annu Rev Immunol 13, 417, 1995.
125. Tada, M., Takahama, Y., Abe, K., Nakatsuji, N. and Tada, T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11, 1553, 2001.
126. Cowan, C.A., Atienza, J., Melton, D.A. and Eggan, K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309, 1369, 2005.
127. Cibelli, J.B., Grant, K.A., Chapman, K.B., Cunniff, K., Worst, T., Green, H.L., Walker, S.J., Gutin, P.H., Vilner, L., Tabar, V., Dominko, T., Kane, J., Wettstein, P.J., Lanza, R.P., Studer, L., Vrana, K.E. and West, M.D. Parthenogenetic stem cells in nonhuman primates. Science 295, 819, 2002.
128. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz- Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W.C., Largaespada, D.A. and Verfaillie, C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41, 2002.
129. Terada, N., Hamazaki, T., Oka, M., Hoki, M., Mastalerz, D.M., Nakano, Y., Meyer, E.M., Morel, L., Petersen, B.E. and Scott, E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542, 2002.
130. Ying, Q.L., Nichols, J., Evans, E.P. and Smith, A.G. Changing potency by spontaneous fusion. Nature 416, 545, 2002.
131. Fok, E.Y. and Zandstra, P.W. Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells 23, 1333, 2005.
132. Cormier, J.T., Nieden, N.I., Rancourt, D.E. and Kallos, M.S. Expansion of undifferentiated murine embryonic stem cells as aggregates in suspension culture bioreactors. Tissue Eng 2006 Oct 1; [Epub ahead of print].
133. Abranches, E., Bekman, E., Henrique, D. and Cabral, J.M. Expansion of mouse embryonic stem cells on microcarriers. Biotechnol Bioeng 96, 1211, 2007.
134. Ryan, E.A., Lakey, J.R., Paty, B.W., Imes, S., Korbutt, G.S., Kneteman, N.M., Bigam, D., Rajotte, R.V. and Shapiro, A.M. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51, 2148, 2002.
135. Segev, H., Fishman, B., Ziskind, A., Shulman, M. and Itskovitz-Eldor, J. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 22, 265, 2004.